IMC Chicago’s Gilead Sciences GILD Stock Holding History

IMC Chicago’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.93M	Buy	+23,216	New	+$3.06M	﹤0.01%	2655
2025 Q4	–	Sell	-43,865	Closed	-$5.33M	–	4197
2025 Q3	$4.87M	Buy	+43,865	New	+$4.99M	﹤0.01%	1579
2025 Q1	–	Sell	-56,703	Closed	-$5.85M	–	3248
2024 Q4	$5.24M	Buy	+56,703	New	+$5.11M	﹤0.01%	1202
2024 Q3	–	Sell	-36,020	Closed	-$2.75M	–	2868
2024 Q2	$2.47M	Sell	36,020 -20,705	-37%	-$1.38M	﹤0.01%	1441
2024 Q1	$4.16M	Sell	56,725 -27,483	-33%	-$2.11M	﹤0.01%	1041
2023 Q4	$6.82M	Buy	84,208 +27,463	+48%	+$2.14M	﹤0.01%	775
2023 Q3	$4.25M	Sell	56,745 -1,447	-2%	-$111K	﹤0.01%	778
2023 Q2	$4.48M	Buy	+58,192	New	+$4.64M	﹤0.01%	697
2023 Q1	–	Sell	-250,858	Closed	-$20.8M	–	1308
2022 Q4	$21.5M	Buy	+250,858	New	+$19.9M	0.03%	292
2022 Q2	–	Sell	-66,666	Closed	-$4.13M	–	1092
2022 Q1	$3.96M	Buy	+66,666	New	+$4.26M	﹤0.01%	604
2021 Q3	–	Sell	-17,768	Closed	-$1.25M	–	1215
2021 Q2	$1.22M	Buy	+17,768	New	+$1.19M	﹤0.01%	868
2020 Q2	–	Sell	-147,473	Closed	-$11.3M	–	920
2020 Q1	$11M	Buy	147,473 +86,254	+141%	+$5.96M	0.02%	202
2019 Q4	$3.98M	Buy	+61,219	New	+$3.99M	0.01%	382

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

IMC Chicago's GILD Position: Q2 2026 in Review

IMC Chicago opened a new position in Gilead Sciences (GILD) in Q2 2026: 23,216 shares worth $2.93M. The stake represents ﹤0.01% of the portfolio and ranks #2655 among its holdings. This is a return to the name: IMC Chicago previously reported a position in GILD as recently as Q3 2025.

IMC Chicago first reported a position in GILD in Q4 2019 and has held it in 13 quarters since. The position peaked at $21.5M in Q4 2022. 2,277 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

IMC Chicago held 23,216 shares of Gilead Sciences worth $2.93M as of Q2 2026.
Gilead Sciences was a new IMC Chicago position in Q2 2026.
Gilead Sciences made up ﹤0.01% of IMC Chicago's portfolio in Q2 2026, its #2655 holding.
IMC Chicago first reported a position in Gilead Sciences in Q4 2019 and has held it in 13 quarters since.
IMC Chicago's Gilead Sciences position peaked at $21.5M in Q4 2022.
2,277 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.